Anastasis’ technology relates to a novel treatment applicable to many cancers.
These cancers depend on rogue cells multiplying uncontrollably caused by DNA abnormalities (mutations) in important pathways involved in the generation of cancer and cancer stem cells. When there are mutations in these pathways, cancer cells and cancer stem cells, run rogue, multiply and spread uncontrollably.
Company Details
- Employees
- 4
- Address
- 56 Haverstock Hill, London,england Nw3 2bh,united Kingdom
- Industry
- Biotechnology
- Website
- http://anastasisbiotec.com
- HQ
- London, England
Anastasis Biotec Questions
Anastasis Biotec's website is http://anastasisbiotec.com
Anastasis Biotec's LinkedIn profile is https://uk.linkedin.com/company/anastasis-biotec
Anastasis Biotec has
4 employees.
View email and phone details for 4
employees at Anastasis Biotec.
Anastasis Biotec's industry is
Biotechnology
Anastasis Biotec's top competitors are
Grove Biopharma, Inc.,
Oncovalent Therapeutics,
Evozyne,
Circ Biosciences,
Kojin Therapeutics,
Vanqua Bio,
Ctrl Therapeutics,
Reax Biotechnologies,
Clostrabio, Inc,
Nimbus Therapeutics.
Anastasis Biotec's categories are Biotechnology
